Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

ChemImage Wins $1M to Commercialize MCF Technology

September 8, 2011 7:18 am | News | Comments

ChemImage announced that it has been selected to receive up to $1 million in funding from the Ohio Third Frontier Advanced Materials Program. The award will be used to establish a manufacturing facility for its multi-conjugate filter technology.

TOPICS:

Abbott Begins Stent Trial

September 8, 2011 7:14 am | News | Comments

Abbott announced the initiation of ABSORB BTK, a clinical trial evaluating the safety and efficacy of the Absorb bioresorbable vascular scaffold for the treatment of below-the-knee critical limb ischemia.

TOPICS:

Ardea, FDA Reach Deal Over Gout Drug

September 8, 2011 6:49 am | News | Comments

Ardea Biosciences Inc. has reached an agreement with the Food and Drug Administration on clinical trials of lesinurad, including the size and design of the studies, their main goals, the safety databases, and manufacturing plans.

TOPICS:
Advertisement

Hi-Tech Pharmacal Profit Bounds 59%

September 8, 2011 6:43 am | News | Comments

Hi-Tech Pharmacal Co. Inc. said its fiscal first-quarter profit climbed 59%, helped by generic drug sales gains. The Amityville, N.Y., company earned $13.8 million in the three months that ended July 31.

TOPICS:

Teva Deal to Fuel P & G Sales

September 8, 2011 6:40 am | News | Comments

Procter & Gamble Co. expects sales in big emerging markets to help offset sluggish sales in the United States and other developed countries. He sees huge potential for expanding P&G health care product sales from a partnership with Teva Pharmaceutical Industries.

TOPICS:

FDA Advisers Set to Review Xarelto

September 8, 2011 6:36 am | News | Comments

A new anticlotting drug that had been seen as a blockbuster comes under scrutiny by a panel of outside advisers to the Food and Drug Administration, two days after a negative review by FDA staff.

TOPICS:

Bridging the Gap

September 8, 2011 6:17 am | by Dwayne Allen, Manager, New Business Development; Ajinomoto Aminoscience, Raleigh, N.C. | Articles | Comments

Traditionally, synthesis of peptides has been done via liquid- or solid-phase processes.  A convergent methodology of peptide synthesis that can produce historically challenging peptides using a consistent process from R&D to commercialization is described.

TOPICS:

PerkinElmer Acquiring Caliper Life Sciences

September 8, 2011 5:14 am | News | Comments

PerkinElmer, Inc. signed a definitive agreement to acquire Caliper Life Sciences, Inc. for $10.50 per share, for a total net purchase price of approximately $600 million.

TOPICS:
Advertisement

Switch Discovered That Turns White Fat Brown

September 7, 2011 12:19 pm | News | Comments

Scientists have discovered a biological switch that gives energy-storing white fat the characteristics of energy-burning brown fat.

Phase 1 of NOX-H94 Initiated for Anemia

September 7, 2011 12:12 pm | News | Comments

Noxxon Pharma announced the initiation of a Phase 1 clinical trial for NOX-H94, the company’s third compound to enter the clinic.

Prostate Cancer Drug Receives European OK

September 7, 2011 12:04 pm | News | Comments

European regulators have approved the Johnson & Johnson pill Zytiga as a treatment for men with advanced prostate cancer who have already undergone chemotherapy.

TOPICS:

Stem Cells Produced From Endangered Species

September 7, 2011 12:00 pm | News | Comments

Starting with normal skin cells, scientists from The Scripps Research Institute have produced the first stem cells from endangered species.

TOPICS:

Royalty Pharma Raises $3.6 Billion in Refinancing

September 7, 2011 11:57 am | News | Comments

Royalty Pharma refinanced $2.75 billion of outstanding debt and funded a one-time $850 million cash distribution to shareholders.

TOPICS:

Study Reveals How Healthy Cells Cannibalize Counterparts

September 7, 2011 11:52 am | News | Comments

Every day, we purge 100 to 200 billion dead or dying cells – a process called cell clearance, which is fundamental in our ability to maintain a healthy physiological balance and prevent a number of chronic diseases.

TOPICS:

Opaque Microplate

September 7, 2011 7:10 am | Product Releases | Comments

Constructed in ultra-pure grade polystyrene, the opaque white Krystal 2000 plate from Porvair Sciences Ltd. maximises reflectivity enabling even weakly emitting luminescence assays to be routinely undertaken.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading